Skip to main content
×
Home
The Recognition and Management of Early Psychosis
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 10
  • Cited by
    This book has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Coentre, Ricardo Blanco, Pablo Fontes, Silvina and Power, Paddy 2011. Initial diagnosis and treatment in first-episode psychosis: can an operationalized diagnostic classification system enhance treating clinicians' diagnosis and the treatment chosen?. Early Intervention in Psychiatry, Vol. 5, Issue. 2, p. 132.


    Hodgson, Kate J. Shelton, Katherine H. and van den Bree, Marianne B. M. 2015. Psychopathology among young homeless people: Longitudinal mental health outcomes for different subgroups. British Journal of Clinical Psychology, Vol. 54, Issue. 3, p. 307.


    O’Donoghue, Brian Roche, Eric and Lane, Abbie 2016. Neighbourhood level social deprivation and the risk of psychotic disorders: a systematic review. Social Psychiatry and Psychiatric Epidemiology, Vol. 51, Issue. 7, p. 941.


    Thomas, Naveen and Pantelis, Christos 2015. The Encyclopedia of Clinical Psychology.


    Alvarez-Jimenez, M. O’Donoghue, B. Thompson, A. Gleeson, J. F. Bendall, S. Gonzalez-Blanch, C. Killackey, E. Wunderink, L. and McGorry, P. D. 2016. Beyond Clinical Remission in First Episode Psychosis: Thoughts on Antipsychotic Maintenance vs. Guided Discontinuation in the Functional Recovery Era. CNS Drugs, Vol. 30, Issue. 5, p. 357.


    Shinn, Ann K. Bolton, Kirsten W. Karmacharya, Rakesh Lewandowski, Kathryn E. Yuksel, Cagri Baker, Justin T. Chouinard, Virginie-Anne Pingali, Samira M. Bye, Hilary Cederbaum, Katherine and Öngür, Dost 2015. McLean OnTrack: a transdiagnostic program for early intervention in first-episode psychosis. Early Intervention in Psychiatry, p. n/a.


    O'Donoghue, Brian Lyne, John Renwick, Laoise Madigan, Kevin Kinsella, Anthony Clarke, Mary Turner, Niall and O'Callaghan, Eadbhard 2012. A descriptive study of ‘non-cases’ and referral rates to an early intervention for psychosis service. Early Intervention in Psychiatry, Vol. 6, Issue. 3, p. 276.


    Tapfumaneyi, Andrew Johnson, Sonia Joyce, John Major, Barnaby Lawrence, Jo Mann, Farhana Chisholm, Brock Rahaman, Nikola Wooley, James and Fisher, Helen L. 2015. Predictors of vocational activity over the first year in inner-city early intervention in psychosis services. Early Intervention in Psychiatry, Vol. 9, Issue. 6, p. 447.


    Thompson, Andrew Nelson, Barnaby Bechdolf, Andreas Chanen, Andrew M. Domingues, Isabel McDougall, Emma and Yung, Alison R. 2012. Borderline personality features and development of psychosis in an ‘Ultra High Risk’ (UHR) population: a case control study. Early Intervention in Psychiatry, Vol. 6, Issue. 3, p. 247.


    Birchwood, Max Jackson, Chris Brunet, Kat Holden, Judith and Barton, Karen 2012. Personal beliefs about illness questionnaire-revised (PBIQ-R): Reliability and validation in a first episode sample. British Journal of Clinical Psychology, Vol. 51, Issue. 4, p. 448.


    ×
  • Export citation
  • Recommend to librarian
  • Recommend this book

    Email your librarian or administrator to recommend adding this book to your organisation's collection.

    The Recognition and Management of Early Psychosis
    • Online ISBN: 9780511576287
    • Book DOI: https://doi.org/10.1017/CBO9780511576287
    Please enter your name
    Please enter a valid email address
    Who would you like to send this to? *
    ×
  • Buy the print book

Book description

Psychotic illness is managed and treated with best results when it is recognized at the earliest stages of a person developing the disorder, or when that person is identified as being at high risk of doing so. Describing a stage-specific model highlighting the risk, the clinical and biological factors present during the development of the illness, and the best treatments available for each of these stages, this new edition will guide practitioners and researchers in the adoption of carefully planned management strategies fully integrating treatment with prevention. Issues such as resistance to drugs and vocational recovery are covered, with related topics such as service organization and community education. This will be essential reading for all those involved in the care of people with early psychotic illness, or those responsible for the organization of services.

Reviews

'… not just an updated version of the first edition … it is a near-total reworking of the entire book … a superb book, and every clinician who encounters patients at risk for psychosis or suffering from first episode psychosis should be familiar with the material it presents.'

Source: Doody's

'The Recognition and Management of Early Psychosis: A Preventive Approach (Second Edition) presents the field of early detection and early intervention in an interesting and informative format. … It is undoubtedly a comprehensive source of information with many references to guide further reading and may also be a useful teaching tool for college and university courses on this topic. … This book is a clear and approachable presentation of early detection and early intervention, and I recommend it strongly.'

Source: The Journal of Psychological Medicine

    • Aa
    • Aa
Refine List
Actions for selected content:
Select all | Deselect all
  • View selected items
  • Export citations
  • Download PDF (zip)
  • Send to Kindle
  • Send to Dropbox
  • Send to Google Drive
  • Send content to

    To send content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about sending content to .

    To send content to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle.

    Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

    Find out more about the Kindle Personal Document Service.

    Please be advised that item(s) you selected are not available.
    You are about to send:
    ×

Save Search

You can save your searches here and later view and run them again in "My saved searches".

Please provide a title, maximum of 40 characters.
×

Page 1 of 2



Page 1 of 2


This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.


International Early Psychosis Writing Group (2005). International clinical practice guidelines for early psychosis. British Journal of Psychiatry, 187(Suppl 48), s120–4.

N. C.Andreasen, (1997). Linking mind and brain in the study of mental illnesses: a project for a scientific psychopathology. Science, 275, 1586–93.

N. C.Andreasen, (2007). DSM and the death of phenomenology in America: an example of unintended consequences. Schizophrenia Bulletin, 33, 108–12.

M.Birchwood, & A.Fiorillo, (2000). The critical period for early intervention. Psychiatric Rehabilitation Skills. Special Issue: The British Approach to Psychiatric Rehabilitation, 4, 182–98.

G. A.Fava, & R.Kellner, (1993). Staging: a neglected dimension in psychiatric classification. Acta Psychiatrica Scandinavica, 87, 225–30.

P. A.Garety, , T. K. J.Craig, , G.Dunn, et al. (2006). Specialised care for early psychosis: symptoms, social functioning and patient satisfaction. British Journal of Psychiatry, 188, 37–45.

T. R.Insel, & W. S.Fenton, (2005). Psychiatric epidemiology: it’s not just about counting anymore. Archives of General Psychiatry, 62, 590–2.

A. F.Jorm, (2000). Mental health literacy: public knowledge and beliefs about mental disorders. British Journal of Psychiatry, 177, 396–401.

A. P.Legorreta, , H. O.Chernicoff, , J. B.Trinh, & R. G.Parker, (2004). Diagnosis, clinical staging, and treatment of breast cancer: a retrospective multiyear study of a large controlled population. American Journal of Clinical Oncology, 27, 185–90.

T. H.McGlashan, , R. B.Zipursky, , D.Perkins, et al. (2006). Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis. American Journal of Psychiatry, 163, 790–9.

T. H.McGlashan, , J.Addington, , T.Cannon, et al. (2007). Recruitment and treatment practices for help-seeking ‘prodromal’ patients. Schizophrenia Bulletin, 33, 715–26.

P. D.McGorry, (2007b). Issues for DSM-V: clinical staging: a heuristic pathway to valid nosology and safer, more effective treatment in psychiatry. American Journal of Psychiatry, 164, 859–60.

P. D.McGorry, , D. L.Copolov, & B. S.Singh, (1989). The validity of the assessment of psychopathology in the psychoses. Australian and New Zealand Journal of Psychiatry, 23, 469–82.

P. D.McGorry, , A. R.Yung, , L. J.Phillips, et al. (2002). Randomized controlled trial of interventions designed to reduce the risk of progression to first episode psychosis in a clinical sample with subthreshold symptoms. Archives of General Psychiatry, 59, 921–8.

P. D.McGorry, , I. B.Hickie, , A. R.Yung, , C.Pantelis, & H. J.Jackson, (2006). Clinical staging of psychiatric disorders: a heuristic framework for choosing earlier, safer and more effective interventions. Australian and New Zealand Journal of Psychiatry, 40, 616–22.

M.Nordentoft, , A.Thorup, , L.Petersen, et al. (2006). Transition rates from schizotypal disorder to psychotic disorder for first-contact patients included in the OPUS trial. A randomized clinical trial of integrated treatment and standard treatment. Schizophrenia Research, 83, 29–40.

V.Patel, , A. J.Flisher, , S.Hetrick, & P.McGorry, (2007). Mental health of young people: a global public-health challenge. Lancet, 369, 1302–13.

D. O.Perkins, , H.Gu, , K.Boteva, & J. A.Lieberman, (2005). Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis. American Journal of Psychiatry, 162, 1785–804.

D.Rice, & S. J.Barone, (2000). Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environmental Health Perspectives, 108(Suppl 3), S511–33.

L.Steinberg, (2005). Cognitive and affective development in adolescence. Trends in Cognitive Sciences, 9, 69–74.

J.van Os, , M.Hanssen, , R. V.Bijl, & A.Ravelli, (2000). Strauss (1969) revisited: a psychosis continuum in the general population? Schizophrenia Research, 45, 11–20.

A.Abi-Dargham, , R. J.Rodenhiser, , D.Printz, et al. (2000). Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. Proceedings of the National Academy of Sciences USA, 97, 8104–9.

M.Allin, & R. M.Murray, (2002). Schizophrenia: a neurodevelopmental or neurodegenerative disorder? Current Opinion in Psychiatry, 15, 9–15.

D.Avramopoulos, , N. C.Stefanis, , I.Hantoumi, et al. (2002). Higher scores of self reported schizotypy in healthy young males carrying the COMT high activity allele. Molecular Psychiatry, 7, 706–11.

J. A.Badner, & E. S.Gershon, (2002). Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia. Molecular Psychiatry, 7, 405–11.

T. A.Bayer, , P.Falkai, & W.Maier, (1999). Genetic and non-genetic vulnerability factors in schizophrenia: the basis of the ‘two hit hypothesis’. Journal of Psychiatric Research, 33, 543–8.

A.Bertolino, , G.Caforio, , G.Blasi, et al. (2004). Interaction of COMT (Val(108/158)Met) genotype and olanzapine treatment on prefrontal cortical function in patients with schizophrenia. American Journal of Psychiatry, 161, 1798–805.

R. M.Bilder, , J.Volavka, , P.Czobor, et al. (2002). Neurocognitive correlates of the COMT Val(158)Met polymorphism in chronic schizophrenia. Biological Psychiatry, 52, 701–7.

D. H.Blackwood, , A.Fordyce, , M. T.Walker, et al. (2001). Schizophrenia and affective disorders – cosegregation with a translocation at chromosome 1q42 that directly disrupts brain-expressed genes: clinical and P300 findings in a family. American Journal of Human Genetics, 69, 428–33.

S. Y.Bookheimer, , M. H.Strojwas, , M. S.Cohen, et al. (2000). Patterns of brain activation in people at risk for Alzheimer’s disease. New England Journal of Medicine, 343, 450–6.

T.Cannon, , M.Huttunen, , J.Lonnqvist, et al. (2000). The inheritance of neuropsychological dysfunction in twins discordant for schizophrenia. American Journal of Human Genetics, 67, 369–82.

P. D.Canoll, , R.Kraemer, , K. K.Teng, , M. A.Marchionni, & J. L.Salzer, (1999). GGF/neuregulin induces a phenotypic reversion of oligodendrocytes. Molecular and Cellular Neuroscience, 13, 79–94.

F.Cassidy, , S.Roche, , E.Claffey, & P.McKeon, (2006). First family-based test for association of neuregulin with bipolar affective disorder. Molecular Psychiatry, 11, 706–7.

X.Chen, , X.Wang, , A. F.O’Neill, , D.Walsh, & K. S.Kendler, (2004). Variants in the catechol-O-methyltransferase (COMT) gene are associated with schizophrenia in Irish high-density families. Molecular Psychiatry, 9, 962–7.

K. V.Chowdari, , K.Mirnics, , P.Semwal, et al. (2002). Association and linkage analyses of RGS4 polymorphisms in schizophrenia. Human Molecular Genetics, 11, 1373–80.

I.Chumakov, , M.Blumenfeld, , O.Guerassimenko, et al. (2002). Genetic and physiological data implicating the new human gene G72 and the gene for d-amino acid oxidase in schizophrenia. Proceedings of the National Academy of Sciences USA, 99, 13675–80.

N.Craddock, , M. C.O’Donovan, & M. J.Owen, (2006). Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology. Schizophrenia Bulletin, 32, 9–16.

K. L.Davis, , M. S.Buchsbaum, , L.Shihabuddin, et al. (1998). Ventricular enlargement in poor-outcome schizophrenia. Biological Psychiatry, 43, 783–93.

K. L.Davis, , D. G.Stewart, , J. I.Friedman, et al. (2003). White matter changes in schizophrenia: evidence for myelin-related dysfunction. Archives of General Psychiatry, 60, 443–56.

L. E.Delisi, (1999a). Defining the course of brain structural change and plasticity in schizophrenia. Psychiatry Research, 92, 1–9.

L. E.Delisi, (1999b). Regional brain volume change over the lifetime course of schizophrenia. Journal of Psychiatric Research, 33, 535–41.

L. E.Delisi, (1999c). Structural brain changes in schizophrenia. Archives of General Psychiatry, 56, 195–6.

S. D.Detera-Wadleigh, & F. J.McMahon, (2006). G72/G30 in schizophrenia and bipolar disorder: review and meta-analysis. Biological Psychiatry, 60, 106–14.

M. F.Egan, , T. E.Goldberg, , T.Gscheidle, et al. (2001b). Relative risk for cognitive impairments in siblings of patients with schizophrenia. Biological Psychiatry, 50, 98–107.

M. F.Egan, , M.Kojima, , J. H.Callicott, et al. (2003). The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell, 112, 257–69.

M. F.Egan, , R. E.Straub, , T. E.Goldberg, et al. (2004). Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia. Proceedings of the National Academy of Sciences USA, 101, 12604–9.

J.Ekelund, , I.Hovatta, , A.Parker, et al. (2001). Chromosome 1 loci in Finnish schizophrenia families. Human Molecular Genetics, 10, 1611–17.

D. L.Falls, (2003). Neuregulins: functions, forms, and signaling strategies. Experimental Cell Research, 284, 14–30.

M. F.Fraga, , E.Ballestar, , M. F.Paz, et al. (2005). Epigenetic differences arise during the lifetime of monozygotic twins. Proceedings of the National Academy of Sciences USA, 102, 10604–9.

B.Funke, , A. K.Malhotra, , C. T.Finn, et al. (2005). COMT genetic variation confers risk for psychotic and affective disorders: a case control study. Behavioral and Brain Functions, 1, 19–27.

J.Gallinat, , M.Bajbouj, , T.Sander, et al. (2003). Association of the G1947A COMT (Val(108/158)Met) gene polymorphism with prefrontal P300 during information processing. Biological Psychiatry, 54, 40–8.

S. J.Glatt, , S. V.Faraone, & M. T.Tsuang, (2003). Association between a functional catechol O-methyltransferase gene polymorphism and schizophrenia: meta-analysis of case-control and family-based studies. American Journal of Psychiatry, 160, 469–76.

T. E.Goldberg, , E. F.Torrey, , J. M.Gold, et al. (1995). Genetic risk of neuropsychological impairment in schizophrenia: a study of monozygotic twins discordant and concordant for the disorder. Schizophrenia Research, 17, 77–84.

T. E.Goldberg, , M. F.Egan, , T.Gscheidle, et al. (2003). Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia. Archives of General Psychiatry, 60, 889–96.

I. I.Gottesman, & T. D.Gould, (2003). The endophenotype concept in psychiatry: etymology and strategic intentions. American Journal of Psychiatry, 160, 636–45.

I. I.Gottesman, & J.Shields, (1967). A polygenic theory of schizophrenia. Proceedings of the National Academy of Sciences USA, 58, 199–205.

E. K.Green, , R.Raybould, , S.MacGregor, et al. (2005). Operation of the schizophrenia susceptibility gene, neuregulin 1, across traditional diagnostic boundaries to increase risk for bipolar disorder. Archives of General Psychiatry, 62, 642–8.

R. E.Gur, , P.Cowell, , B. I.Turetsky, et al. (1998). A follow-up magnetic resonance imaging study of schizophrenia. Relationship of neuroanatomical changes to clinical and neurobehavioral measures. Archives of General Psychiatry, 55, 145–52.

Y.Hakak, , J. R.Walker, , C.Li, et al. (2001). Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proceedings of the National Academy of Sciences USA, 98, 4746–51.

D.Hall, , A.Dhilla, , A.Charalambous, , J. A.Gogos, & M.Karayiorgou, (2003). Sequence variants of the brain-derived neurotrophic factor (BDNF) gene are strongly associated with obsessive-compulsive disorder. American Journal of Human Genetics, 73, 370–6.

H. Y.Handoko, , D. R.Nyholt, , N. K.Hayward, et al. (2005). Separate and interacting effects within the catechol-O-methyltransferase (COMT) are associated with schizophrenia. Molecular Psychiatry, 10, 589–97.

P. J.Harrison, & A. J.Law, (2006). Neuregulin 1 and schizophrenia: genetics, gene expression, and neurobiology. Biological Psychiatry, 60, 132–40.

R.Hashimoto, , R. E.Straub, , C. S.Weickert, et al. (2004). Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophrenia. Molecular Psychiatry, 9, 299–307.

Z.Hawi, , R. E.Straub, , A.O’Neill, et al. (1998). No linkage or linkage disequilibrium between brain-derived neurotrophic factor (BDNF) dinucleotide repeat polymorphism and schizophrenia in Irish families. Psychiatry Research, 81, 111–16.

W.Hennah, , T.Varilo, , M.Kestila, et al. (2003). Haplotype transmission analysis provides evidence of association for DISC1 to schizophrenia and suggests sex-dependent effects. Human Molecular Genetics, 12, 3151–9.

H.Herken, & M. E.Erdal, (2001). Catechol-O-methyltransferase gene polymorphism in schizophrenia: evidence for association between symptomatology and prognosis. Psychiatric Genetics, 11, 105–9.

C. A.Hodgkinson, , D.Goldman, , J.Jaeger, et al. (2004). Disrupted in schizophrenia 1 (DISC1): association with schizophrenia, schizoaffective disorder, and bipolar disorder. American Journal of Human Genetics, 75, 862–72.

E. G.Holliday, , H. Y.Handoko, , M. R.James, et al. (2006). Association study of the dystrobrevin-binding gene with schizophrenia in Australian and Indian samples. Twin Research and Human Genetics, 9, 531–9.

C. J.Hong, , Y. W.Yu, , C. H.Lin, & S. J.Tsai, (2003). An association study of a brain-derived neurotrophic factor Val66Met polymorphism and clozapine response of schizophrenic patients. Neuroscience Letters, 349, 206–8.

I.Hovatta, , D.Lichtermann, , H.Juvonen, et al. (1998). Linkage analysis of putative schizophrenia gene candidate regions on chromosomes 3p, 5q, 6p, 8p, 20p and 22q in a population-based sampled Finnish family set. Molecular Psychiatry, 3, 452–7.

S.Iritani, , K.Niizato, , H.Nawa, , K.Ikeda, & P. C.Emson, (2003). Immunohistochemical study of brain-derived neurotrophic factor and its receptor, TrkB, in the hippocampal formation of schizophrenic brains. Progress in Neuropsychopharmacology and Biological Psychiatry, 27, 801–7.

A.Jablensky, (1999). The concept of schizophrenia: pro et contra. Epidemiologia e Psichiatria Sociale, 8, 242–7.

E.Jablonka, & M. J.Lamb, (2002). The changing concept of epigenetics. Annals of the New York Academy of Sciences, 981, 82–96.

L. K.Jacobsen, , J. N.Giedd, , F. X.Castellanos, et al. (1998). Progressive reduction of temporal lobe structures in childhood-onset schizophrenia. American Journal of Psychiatry, 155, 678–85.

G.Jones, , S.Zammit, , N.Norton, et al. (2001). Aggressive behaviour in patients with schizophrenia is associated with catechol-O-methyltransferase genotype. British Journal of Psychiatry, 179, 351–5.

K. S.Kendler, (2004). Schizophrenia genetics and dysbindin: a corner turned? American Journal of Psychiatry, 161, 1533–6.

M. S.Keshavan, (1999). Development, disease and degeneration in schizophrenia: a unitary pathophysiological model. Journal of Psychiatric Research, 33, 513–21.

M. O.Krebs, , O.Guillin, , M. C.Bourdell, et al. (2000). Brain derived neurotrophic factor (BDNF) gene variants association with age at onset and therapeutic response in schizophrenia. Molecular Psychiatry, 5, 558–62.

I.Kremer, , M.Pinto, , I.Murad, et al. (2003). Family-based and case-control study of catechol-O-methyltransferase in schizophrenia among Palestinian Arabs. American Journal of Medical Genetics, 119B, 35–9.

A. J.Law, , C.Shannon Weickert, , T. M.Hyde, , J. E.Kleinman, & P. J.Harrison, (2004). Neuregulin-1 (NRG-1) mRNA and protein in the adult human brain. Neuroscience, 127, 125–36.

A. J.Law, , B. K.Lipska, , C. S.Weickert, et al. (2006). Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5′ SNPs associated with the disease. Proceedings of the National Academy of Sciences USA, 103, 6747–52.

D. F.Levinson, , P. A.Holmans, , C.Laurent, et al. (2002). No major schizophrenia locus detected on chromosome 1q in a large multicenter sample. Science, 296, 739–41.

C. M.Lewis, , D. F.Levinson, , L. H.Wise, et al. (2003). Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: schizophrenia. American Journal of Human Genetics, 73, 34–48.

D. A.Lewis, , T.Hashimoto, & D. W.Volk, (2005). Cortical inhibitory neurons and schizophrenia. Nature Reviews Neuroscience, 6, 312–24.

M. A.Lewis, , L.Hunihan, , D.Franco, et al. (2006). Identification and characterization of compounds that potentiate NT-3-mediated Trk receptor activity. Molecular Pharmacology, 69, 1396–404.

D.Li, , D. A.Collier, & L.He, (2006). Meta-analysis shows strong positive association of the neuregulin 1 (NRG1) gene with schizophrenia. Human Molecular Genetics, 15, 1995–2002.

B. K.Lipska, , S.Mitkus, , M.Caruso, et al. (2006a). RGS4 mRNA expression in postmortem human cortex is associated with COMT Val158Met genotype and COMT enzyme activity. Human Molecular Genetics, 15, 2804–12.

B. K.Lipska, , T.Peters, , T. M.Hyde, et al. (2006b). Expression of DISC1 binding partners is reduced in schizophrenia and associated with DISC1 SNPs. Human Molecular Genetics, 15, 1245–58.

D. H.Mathalon, , E. V.Sullivan, , K. O.Lim, & A.Pfefferbaum, (2001). Progressive brain volume changes and the clinical course of schizophrenia in men: a longitudinal magnetic resonance imaging study. Archives of General Psychiatry, 58, 148–57.

A.Meyer-Lindenberg, & D. R.Weinberger, (2006). Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nature Reviews Neuroscience, 7, 818–27.

A.Meyer-Lindenberg, , T.Nichols, , J. H.Callicott, et al. (2006a). Impact of complex genetic variation in COMT on human brain function. Molecular Psychiatry, 11, 867–77.

A.Meyer-Lindenberg, , C. B.Mervis, & K. F.Berman, (2006b). Neural mechanisms in Williams’ syndrome: a unique window to genetic influences on cognition and behaviour. Nature Reviews Neuroscience, 7, 380–93.

J. K.Millar, , J. C.Wilson-Annan, , S.Anderson, et al. (2000). Disruption of two novel genes by a translocation co-segregating with schizophrenia. Human Molecular Genetics, 9, 1415–23.

K.Mirnics, , F. A.Middleton, , G. D.Stanwood, , D. A.Lewis, & P.Levitt, (2001). Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia. Molecular Psychiatry, 6, 293–301.

P.Muglia, , A. M.Vicente, , M.Verga, et al. (2003). Association between the BDNF gene and schizophrenia. Molecular Psychiatry, 8, 146–7.

M. RMunafo, , L.Bowes, , T. G.Clark, & J.Flint, (2005). Lack of association of the COMT (Val(158/108) Met) gene and schizophrenia: a meta–analysis of case–control studies. Molecular Psychiatry, 10, 765–70.

M.Neves-Pereira, , E.Mundo, , P.Muglia, et al. (2002). The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study. American Journal of Human Genetics, 71, 651–5.

K. K.Nicodemus, , B. S.Kolachana, , R.Vakkalanka, et al. (2007). Evidence for statistical epistasis between catechol-O-methyltransferase (COMT) and polymorphisms in RGS4, G72 (DAOA), GRM3, and DISC1: influence on risk of schizophrenia. Human Genetics, 120, 889–906.

M. J.Owen, , P.Holmans, & P.McGuffin, (1997). Association studies in psychiatric genetics. Molecular Psychiatry, 2, 270–3.

M. J.Owen, , N. M.Williams, & M. C.O’Donovan, (2004). The molecular genetics of schizophrenia: new findings promise new insights. Molecular Psychiatry, 9, 14–27.

Y.Ozeki, , T.Tomoda, , J.Kleiderlein, et al. (2003). Disrupted-in-schizophrenia-1 (DISC-1): mutant truncation prevents binding to NudE-like (NUDEL) and inhibits neurite outgrowth. Proceedings of the National Academy of Sciences USA, 100, 289–94.

C.Pantelis, , D.Velakoulis, , P. D.McGorry, et al. (2003). Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet, 361, 281–8.

A.Petronis, , I. I.Gottesman, , P.Kan, et al. (2003). Monozygotic twins exhibit numerous epigenetic differences: clues to twin discordance? Schizophrenia Bulletin, 29, 169–78.

J. L.Rapoport, , J.Giedd, , S.Kumra, et al. (1997). Childhood-onset schizophrenia. Progressive ventricular change during adolescence. Archives of General Psychiatry, 54, 897–903.

R.Raybould, , E. K.Green, , S.MacGregor, et al. (2005). Bipolar disorder and polymorphisms in the dysbindin gene (DTNBP1). Biological Psychiatry, 57, 696–701.

M.Ribases, , M.Gratacos, , L.Armengol, et al. (2003). Met66 in the brain-derived neurotrophic factor (BDNF) precursor is associated with anorexia nervosa restrictive type. Molecular Psychiatry, 8, 745–51.

N.Risch, & K.Merikangas, (1996). The future of genetic studies of complex human diseases. Science, 273, 1516–17.

A.Rocchi, , S.Pellegrini, , G.Siciliano, & L.Murri, (2003). Causative and susceptibility genes for Alzheimer’s disease: a review. Brain Research Bulletin, 61, 1–24.

J. K.Rybakowski, , A.Borkowska, , P. M.Czerski, & J.Hauser, (2002). Eye movement disturbances in schizophrenia and a polymorphism of catechol-O-methyltransferase gene. Psychiatry Research, 113, 49–57.

A. R.Sanders, , I.Rusu, , J.Duan, et al. (2005). Haplotypic association spanning the 22q11.21 genes COMT and ARVCF with schizophrenia. Molecular Psychiatry, 10, 353–65.

T.Sasaki, , X. Y.Dai, , S.Kuwata, et al. (1997). Brain-derived neurotrophic factor gene and schizophrenia in Japanese subjects. American Journal of Medical Genetics, 74, 443–4.

S. G.Schwab, , M.Knapp, , S.Mondabon, et al. (2003). Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families. American Journal of Human Genetics, 72, 185–90.

K. B.Seroogy, , K. H.Lundgren, , T. M.Tran, et al. (1994). Dopaminergic neurons in rat ventral midbrain express brain-derived neurotrophic factor and neurotrophin-3 mRNAs. Journal of Comprehensive Neurology, 342, 321–34.

S.Shifman, , M.Bronstein, , M.Sternfeld, et al. (2002). A highly significant association between a COMT haplotype and schizophrenia. American Journal of Human Genetics, 71, 1296–302.

S. L.Slager, & D. J.Schaid, (2001). Evaluation of candidate genes in case–control studies: a statistical method to account for related subjects. American Journal of Human Genetics, 68, 1457–62.

H.Stefansson, , J.Sarginson, , A.Kong, et al. (2003). Association of neuregulin 1 with schizophrenia confirmed in a Scottish population. American Journal of Human Genetics, 72, 83–7.

R. E.Straub, , Y.Jiang, , C. J.MacLean, et al. (2002). Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. American Journal of Human Genetics, 71, 337–48.

R. D.Strous, , K. A.Nolan, , R.Lapidus, et al. (2003). Aggressive behaviour in schizophrenia is associated with the low enzyme activity COMT polymorphism: a replication study. American Journal of Medical Genetics, 120B, 29–34.

P. F.Sullivan, , K. S.Kendler, & M. C.Neale, (2003). Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Archives of General Psychiatry, 60, 1187–92.

G.Szekeres, , A.Juhasz, , A.Rimanoczy, , S.Keri, & Z.Janka, (2003). The C270T polymorphism of the brain-derived neurotrophic factor gene is associated with schizophrenia. Schizophrenia Research, 65, 15–18.

M.Takahashi, , O.Shirakawa, , K.Toyooka, et al. (2000). Abnormal expression of brain-derived neurotrophic factor and its receptor in the corticolimbic system of schizophrenic patients. Molecular Psychiatry, 5, 293–300.

K.Talbot, , W. L.Eidem, , C. L.Tinsley, et al. (2004). Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia. Journal of Clinical Investigation, 113, 1353–63.

M. E.Talkowski, , H.Seltman, , A. S.Bassett, et al. (2006). Evaluation of a susceptibility gene for schizophrenia: genotype based meta-analysis of RGS4 polymorphisms from thirteen independent samples. Biological Psychiatry, 60, 152–62.

J. X.Tang, , W. Y.Chen, , G.He, et al. (2004). Polymorphisms within 5′ end of the neuregulin 1 gene are genetically associated with schizophrenia in the Chinese population. Molecular Psychiatry, 9, 11–12.

M.Tochigi, , X.Zhang, , J.Ohashi, et al. (2006). Association study of the dysbindin (DTNBP1) gene in schizophrenia from the Japanese population. Neuroscience Research, 56, 45–7.

S. J.Tsai, , Y. W.Yu, , T. J.Chen, et al. (2003). Association study of a functional catechol-O-methyltransferase gene polymorphism and cognitive function in healthy females. Neuroscience Letters, 338, 123–6.

M. T.Tsuang, , W. S.Stone, , S. I.Tarbox, & S. V.Faraone, (2002). An integration of schizophrenia with schizotypy: identification of schizotaxia and implications for research on treatment and prevention. Schizophrenia Research, 54, 169–75.

J.van Os, , C.Gilvarry, , R.Bale, et al. (2000). Diagnostic value of the DSM and ICD categories of psychosis: an evidence-based approach. UK700 Group. Social Psychiatry and Psychiatric Epidemiology, 35, 305–11.

D.Velakoulis, , S. J.Wood, , P. D.McGorry, & C.Pantelis, (2000). Evidence for progression of brain structural abnormalities in schizophrenia: beyond the neurodevelopmental model. Australian and New Zealand Journal of Psychiatry, 34, 113–26.

D.Velakoulis, , G. W.Stuart, , S. J.Wood, et al. (2001). Selective bilateral hippocampal volume loss in chronic schizophrenia. Biological Psychiatry, 50, 531–9.

M.Ventriglia, , L.Bocchio Chiavetto, , L.Benussi, et al. (2002). Association between the BDNF 196 A/G polymorphism and sporadic Alzheimer’s disease. Molecular Psychiatry, 7, 136–7.

C.Virgos, , L.Martorell, , J.Valero, et al. (2001). Association study of schizophrenia with polymorphisms at six candidate genes. Schizophrenia Research, 49, 65–71.

T. H.Wassink, , J. J.Nelson, , R. R.Crowe, & N. C.Andreasen, (1999). Heritability of BDNF alleles and their effect on brain morphology in schizophrenia. American Journal of Medical Genetics, 88, 724–8.

C. S.Weickert, , R. E.Straub, , B. W.McClintock, et al. (2004). Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain. Archives of General Psychiatry, 61, 544–55.

C. S.Weickert, , D. L.Ligons, , T.Romanczyk, et al. (2005). Reductions in neurotrophin receptor mRNAs in the prefrontal cortex of patients with schizophrenia. Molecular Psychiatry, 10, 637–50.

D. R.Weinberger, (1987). Implications of normal brain development for the pathogenesis of schizophrenia. Archives of General Psychiatry, 44, 660–9.

D. R.Weinberger, & R. K.McClure, (2002). Neurotoxicity, neuroplasticity, and magnetic resonance imaging morphometry: what is happening in the schizophrenic brain? Archives of General Psychiatry, 59, 553–8.

H. J.Williams, , B.Glaser, , N. M.Williams, et al. (2005). No association between schizophrenia and polymorphisms in COMT in two large samples. American Journal of Psychiatry, 162, 1736–8.

N. M.Williams, , A.Preece, , G.Spurlock, et al. (2003). Support for genetic variation in neuregulin 1 and susceptibility to schizophrenia. Molecular Psychiatry, 8, 485–7.

N. M.Williams, , A.Preece, , G.Spurlock, et al. (2004). Support for RGS4 as a susceptibility gene for schizophrenia. Biological Psychiatry, 55, 192–5.

G.Winterer, , M. F.Egan, , B. S.Kolachana, et al. (2006). Prefrontal electrophysiologic ‘noise’ and catechol-O-methyltransferase genotype in schizophrenia. Biological Psychiatry, 60, 578–84.

J. Z.Yang, , T. M.Si, , Y.Ruan, et al. (2003). Association study of neuregulin 1 gene with schizophrenia. Molecular Psychiatry, 8, 706–9.

A. R.Yung, , H. P.Yuen, , G.Berger, et al. (2007). Declining transition rate in ultra high risk (prodromal) services: dilution or reduction of risk? Schizophrenia Bulletin, 33, 673–81.

M.Baron, & R.Gruen, (1988). Risk factors in schizophrenia. Season of birth and family history. [See comments.] British Journal of Psychiatry, 152, 460–5.

M.Byrne, , E.Agerbo, , H.Ewald, , W. W.Eaton, & P. B.Mortensen, (2003). Parental age and risk of schizophrenia: a case– control study. Archives of General Psychiatry, 60, 673–8.

M.Cannon, & M. C.Clarke, (2005). Risk for schizophrenia: broadening the concepts, pushing back the boundaries. Schizophrenia Research, 79, 5–13.

T. D.Cannon, , S. A.Mednick, , J.Parnas, et al. (1993). Developmental brain abnormalities in the offspring of schizophrenic mothers. I. Contributions of genetic and perinatal factors [see comments]. Archives of General Psychiatry, 50, 551–64.

T. D.Cannon, , T. G.van Erp, , I. M.Rosso, et al. (2002). Fetal hypoxia and structural brain abnormalities in schizophrenic patients, their siblings, and controls. Archives of General Psychiatry, 59, 35–41.

J. W.Carter, , J.Parnas, , T. D.Cannon, , F.Schulsinger, & S. A.Mednick, (1999). MMPI variables predictive of schizophrenia in the Copenhagen High-Risk Project: a 25-year follow-up. Acta Psychiatrica Scandinavica, 99, 432–40.

J. W.Carter, , F.Schulsinger, , J.Parnas, , T.Cannon, & S. A.Mednick, (2002). A multivariate prediction model of schizophrenia. Schizophrenia Bulletin, 28, 649–82.

A.Caspi, & T. E.Moffitt, (2006). Gene–environment interactions in psychiatry: joining forces with neuroscience. Nature Review Neuroscience, 7, 583–90.

A.Caspi, , J.McClay, , T. E.Moffitt, et al. (2002). Role of genotype in the cycle of violence in maltreated children. Science, 297, 851–4.

A.Caspi, , K.Sugden, , T. E.Moffitt, et al. (2003). Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science, 301, 386–9.

A.Caspi, , T. E.Moffitt, , M.Cannon, et al. (2005). Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction. Biological Psychiatry, 57, 1117–27.

H. M.Colhoun, , P. M.McKeigue, & G.Davey-Smith, (2003). Problems of reporting genetic associations with complex outcomes. Lancet, 361, 865–72.

N.Craddock, , M. J.Owen, & M. C.O’Donovan, (2006). The catechol-O-methyltransferase (COMT) gene as a candidate for psychiatric phenotypes: evidence and lessons. Molecular Psychiatry, 11, 446–58.

J.Darroch, (1997). Biologic synergism and parallelism. [See comments.] American Journal of Epidemiology, 145, 661–8.

D.Dassa, , P. C.Sham, , J.van Os, et al. (1996). Relationship of birth season to clinical features, family history, and obstetric complication in schizophrenia. Psychiatry Research, 64, 11–17.

J. O.Davis, & J. A.Phelps, (1995). Twins with schizophrenia: genes or germs? Schizophrenia Bulletin, 21, 13–18.

D. M.Fergusson, , R.Poulton, , P. F.Smith, & J. M.Boden, (2006). Cannabis and psychosis. British Medical Journal, 332, 172–5.

M.Fischer, (1971). Psychoses in the offspring of schizophrenic monozygotic twins and their normal co-twins. British Journal of Psychiatry, 118, 43–52.

J.Flint, (1992). Implications of genomic imprinting for psychiatric genetics. Psychological Medicine, 22, 5–10.

I. I.Gottesman, & A.Bertelsen, (1989). Confirming unexpressed genotypes for schizophrenia. Risks in the offspring of Fischer’s Danish identical and fraternal discordant twins. [See comments.] Archives of General Psychiatry, 46, 867–72.

I. I.Gottesman, &, J.Shields, (1976). A critical review of recent adoption, twin, and family studies of schizophrenia: behavioral genetics perspectives. Schizophrenia Bulletin, 2, 360–401.

D.Hamer, (2002). Genetics. Rethinking behavior genetics. Science, 298, 71–2.

M.Hanssen, , L.Krabbendam, , M.Vollema, , P.Delespaul, & J.van Os, (2006). Evidence for instrument and family-specific variation of subclinical psychosis dimensions in the general population. Journal of Abnormal Psychology, 115, 5–14.

G.Harrison, , C.Glazebrook, , J.Brewin, et al. (1997). Increased incidence of psychotic disorders in migrants from the Caribbean to the United Kingdom. Psychological Medicine, 27, 799–806.

P. J.Harrison, & D. R.Weinberger, (2005). Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Molecular Psychiatry, 10, 40–68; image 5.

C.Henquet, , L.Krabbendam, , J.Spauwen, et al. (2005). Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. British Medical Journal, 330, 11–14.

C.Henquet, , A.Rosa, , L.Krabbendam, et al. (2006). An experimental study of catechol-O-methyltransferase Val158Met moderation of delta-9-tetrahydrocannabinol-induced effects on psychosis and cognition. Neuropsychopharmacology, 31, 2748–57.

G.Hutchinson, , N.Takei, , T. A.Fahy, et al. (1996). Morbid risk of schizophrenia in first-degree relatives of white and African-Caribbean patients with psychosis. British Journal of Psychiatry, 169, 776–80.

N.Jacobs, , I.Myin-Germeys, , C.Derom, , RVlietinck, & J.van Os, (2005). Deconstructing the familiality of the emotive component of psychotic experiences in the general population. Acta Psychiatrica Scandinavica, 112, 394–401.

K. S.Kendler, (2005). ‘A gene for . . .’: the nature of gene action in psychiatric disorders. American Journal of Psychiatry, 162, 1243–52.

K. S.Kendler, (2006). Reflections on the relationship between psychiatric genetics and psychiatric nosology. American Journal of Psychiatry, 163, 1138–46.

M. J.Khoury, , R.Millikan, , J.Little, & M.Gwinn, (2004). The emergence of epidemiology in the genomics age. International Journal of Epidemiology, 33, 936–44.

J.Kirkbride, , P.Fearon, , C.Morgan, et al. (2006). Heterogeneity in incidence rates of schizophrenia and other psychotic syndromes: findings from the 3-centre ÆSOP study. Archives of General Psychiatry, 63, 250–8.

E.Kringlen, & G.Cramer, (1989). Offspring of monozygotic twins discordant for schizophrenia. Archives of General Psychiatry, 46, 873–7.

H.Kunugi, , S.Nanko, , N.Takei, et al. (1996). Perinatal complications and schizophrenia. Data from the Maternal and Child Health Handbook in Japan. Journal of Nervous and Mental Disease, 184, 542–6.

Y. M.Linney, , E. R.Peters, & P.Ayton, (1998). Reasoning biases in delusion-prone individuals. British Journal of Clinical Psychology, 37(Pt 3), 285–302.

Y. M.Linney, , R. M.Murray, , E. R.Peters, et al. (2003). A quantitative genetic analysis of schizotypal personality traits. Psychological Medicine, 33, 803–16.

D.Malaspina, , S.Harlap, , S.Fennig, et al. (2001). Advancing paternal age and the risk of schizophrenia. Archives of General Psychiatry, 58, 361–7.

M.Marcelis, , J.van Os, , P.Sham, et al. (1998). Obstetric complications and familial morbid risk of psychiatric disorders. American Journal of Medical Genetics, 81, 29–36.

J.McGrath, , S.Saha, , J.Welham, et al. (2004). A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology. BMC Medicine, 2, 13.

T. E.Moffitt, , A.Caspi, & M.Rutter, (2005). Strategy for investigating interactions between measured genes and measured environments. Archives of General Psychiatry, 62, 473–81.

P. B.Mortensen, , C. B.Pedersen, , T.Westergaard, et al. (1999). Effects of family history and place and season of birth on the risk of schizophrenia. [See comments.] New England Journal of Medicine, 340, 603–8.

V. L.Nimgaonkar, , S.Wessely, & R. M.Murray, (1988). Prevalence of familiality, obstetric complications, and structural brain damage in schizophrenic patients. British Journal of Psychiatry, 153, 191–7.

N.Norton, , H. J.Williams, & M. J.Owen, (2006). An update on the genetics of schizophrenia. Current Opinion in Psychiatry, 19, 158–64.

E.O’Callaghan, , T.Gibson, , H. A.Colohan, et al. (1992). Risk of schizophrenia in adults born after obstetric complications and their association with early onset of illness: a controlled study. [See comments.] British Medical Journal, 305, 1256–9.

R.Plomin, , J. C.DeFries, & J. C.Loehlin, (1977). Genotype–environment interaction and correlation in the analysis of human behavior. Psychological Bulletin, 84, 309–22.

A. E.Pulver, , K. Y.Liang, , C. H.Brown, et al. (1992). Risk factors in schizophrenia. Season of birth, gender, and familial risk [see comments]. British Journal of Psychiatry, 160, 65–71.

M.Rutter, , T. E.Moffitt, & A.Caspi, (2006). Gene–environment interplay and psychopathology: multiple varieties but real effects. Journal of Child Psychology and Psychiatry, 47, 226–61.

E.Shur, (1982). Season of birth in high and low genetic risk schizophrenics. British Journal of Psychiatry, 140, 410–15.

A.Sipos, , F.Rasmussen, , G.Harrison, et al. (2004). Paternal age and schizophrenia: a population based cohort study. British Medical Journal, 329, 1070–3.

J.Spauwen, , L.Krabbendam, , R.Lieb, , H. U.Wittchen, & J.van Os, (2006a). Evidence that the outcome of developmental expression of psychosis is worse for adolescents growing up in an urban environment. Psychological Medicine, 36, 407–15.

J.Spauwen, , L.Krabbendam, , R.Lieb, , H. U.Wittchen, & J.van Os, (2006b). Impact of psychological trauma on the development of psychotic symptoms: relationship with psychosis proneness. British Journal of Psychiatry, 188, 527–33.

N. C.Stefanis, , C.Henquet, , D.Avramopoulos, et al. (2007). COMT Val158Met moderation of stress-induced psychosis. Psychological Medicine, 37, 1–6.

R. E.Straub, & D. R.Weinberger, (2006). Schizophrenia genes; famine to feast. Biological Psychiatry, 60, 81–3.

P. A.Sugarman, & D.Craufurd, (1994). Schizophrenia in the Afro-Caribbean community. British Journal of Psychiatry, 164, 474–80.

P.Tienari, , L. C.Wynne, , A.Sorri, et al. (2004). Genotype–environment interaction in schizophrenia-spectrum disorder. Long-term follow-up study of Finnish adoptees. British Journal of Psychiatry, 184, 216–22.

E. M.Tunbridge, , P. J.Harrison, & D. R.Weinberger, (2006). Catechol-O-methyltransferase, cognition, and psychosis: val(158)met and beyond. Biological Psychiatry, 60, 141–51.

J.van Os, , C. B.Pedersen, & P. B.Mortensen, (2004). Confirmation of synergy between urbanicity and familial liability in the causation of psychosis. American Journal of Psychiatry, 161, 2312–14.

H.Verdoux, , C.Gindre, , F.Sorbara, , M.Tournier, & J. D.Swendsen, (2003). Effects of cannabis and psychosis vulnerability in daily life: an experience sampling test study. Psychological Medicine, 33, 23–32.

K. E.Wahlberg, , L. C.Wynne, , H.Hakko, et al. (2004). Interaction of genetic risk and adoptive parent communication deviance: longitudinal prediction of adoptee psychiatric disorders. Psychological Medicine, 34, 1531–41.

E.Walker, (1981). Attentional and neuromotor functions of schizophrenics, schizoaffectives, and patients with other affective disorders. Archives of General Psychiatry, 38, 1355–8.

I. C.Weaver, , N.Cervoni, , F. A.Champagne, et al. (2004). Epigenetic programming by maternal behavior. Nature Neuroscience, 7, 847–54.

M. Y.Wong, , N. E.Day, , J. A.Luan, , K. P.Chan, & N. J.Wareham, (2003). The detection of gene–environment interaction for continuous traits: should we deal with measurement error by bigger studies or better measurement? International Journal of Epidemiology, 32, 51–7.

S.Zammit, , P.Allebeck, , C.Dalman, et al. (2003). Paternal age and risk for schizophrenia. British Journal of Psychiatry, 183, 405–8.

A. M.Addington, , M.Gornick, , J.Duckworth, et al. (2005). GAD1 (2q31.1), which encodes glutamic acid decarboxylase (GAD(67)), is associated with childhood-onset schizophrenia and cortical gray matter volume loss. Molecular Psychiatry, 10, 581–8.

E.Armstrong, , A.Schleicher, , H.Omran, , M.Curtis, & K.Zilles, (1995). The ontogeny of human gyrification. Cerebral Cortex, 5, 56–63.

M. R.Asato, , J. A.Sweeney, & B.Luna, (2006). Cognitive processes in the development of TOL performance. Neuropsychologia, 44, 2259–69.

W. F.Baaré, , C. J.van Oel, , H. E.Hulshoff Pol, et al. (2001). Volumes of brain structures in twins discordant for schizophrenia. Archives of General Psychiatry, 58, 33–40.

F. M.Benes, (2007). Searching for unique endophenotypes for schizophrenia and bipolar disorder within neural circuits and their molecular regulatory mechanisms. Schizophrenia Bulletin, 33, 932–6.

A.Bertolino, , J. H.Callicott, , I.Elman, et al. (1998). Regionally specific neuronal pathology in untreated patients with schizophrenia: a proton magnetic resonance spectroscopic imaging study. Biological Psychiatry, 43, 641–8.

D. H.Blackwood, , D. M.St Clair, , W. J.Muir, & J. C.Duffy, (1991). Auditory P300 and eye tracking dysfunction in schizophrenic pedigrees. Archives of General Psychiatry, 48, 899–909.

H. B.Boos, , A.Aleman, , W.Cahn, , H. H.Pol, & R. S.Kahn, (2007). Brain volumes in relatives of patients with schizophrenia: a meta-analysis. Archives of General Psychiatry, 64, 297–304.

D. L.Braff, , R.Freedman, , N. J.Schork, & II.Gottesman, (2007). Deconstructing schizophrenia: an overview of the use of endophenotypes in order to understand a complex disorder. Schizophrenia Bulletin, 33, 21–32.

E.Bramon, , M.Shaikh, , M.Broome, et al. (2008). Abnormal P300 in people with high risk of developing psychosis. Neuroimage, 41, 553–60.

W. J.Brewer, , S. J.Wood, , P. D.McGorry, et al. (2003). Impairment of olfactory identification ability in individuals at ultra-high risk for psychosis who later develop schizophrenia. American Journal of Psychiatry, 160, 1790–4.

W. J.Brewer, , S. M.Francey, , S. J.Wood, et al. (2005). Memory impairments identified in people at ultra-high risk for psychosis who later develop first-episode psychosis. American Journal of Psychiatry, 162, 71–8.

W. J.Brewer, , C.Pantelis, , C. R.De Luca, & S. J.Wood, (2006b). Olfactory processing and brain maturation. In W. J.Brewer , D. J.Castle & C.Pantelis (eds.), Olfaction and the Brain. Cambridge, UK: Cambridge University Press, pp. 103–18.

W. J.Brewer, , M.Yucel, , B. J.Harrison, et al. (2007). Increased prefrontal cerebral blood flow in first-episode schizophrenia following treatment: longitudinal positron emission tomography study. Australian and New Zealand Journal of Psychiatry, 41, 129–35.

A.Brockhaus-Dumke, , I.Tendolkar, , R.Pukrop, et al. (2005). Impaired mismatch negativity generation in prodromal subjects and patients with schizophrenia. Schizophrenia Research, 73, 297–310.

M.Byrne, , A.Hodges, , E.Grant, , D. G.Owens, & E. C.Johnstone, (1999). Neuropsychological assessment of young people at high genetic risk for developing schizophrenia compared with controls: preliminary findings of the Edinburgh High Risk Study (EHRS). Psychological Medicine, 29, 1161–73.

A.Cachia, , M. L.Paillere-Martinot, , A.Galinowski, et al. (2008). Cortical folding abnormalities in schizophrenia patients with resistant auditory hallucinations. Neuroimage, 39, 927–35.

K. S.Cadenhead, , G. A.Light, , M. A.Geyer, & D. L.Braff, (2000). Sensory gating deficits assessed by the P50 event-related potential in subjects with schizotypal personality disorder. American Journal of Psychiatry, 157, 55–9.

K. S.Cadenhead, , G. A.Light, , K. M.Shafer, & D. L.Braff, (2005). P50 suppression in individuals at risk for schizophrenia: the convergence of clinical, familial, and vulnerability marker risk assessment. Biological Psychiatry, 57, 1504–9.

J. H.Callicott, , R. E.Straub, , L.Pezawas, et al. (2005). Variation in DISC1 affects hippocampal structure and function and increases risk for schizophrenia. Proceedings of the National Academy of Sciences USA, 102, 8627–32.

L. M.Camargo, , V.Collura, , J. C.Rain, et al. (2007). Disrupted in schizophrenia 1 interactome: evidence for the close connectivity of risk genes and a potential synaptic basis for schizophrenia. Molecular Psychiatry, 12, 74–86.

T. D.Cannon, (2005a). Clinical and genetic high-risk strategies in understanding vulnerability to psychosis. Schizophrenia Research, 79, 35–44.

T. D.Cannon, (2005b). The inheritance of intermediate phenotypes for schizophrenia. Current Opinion in Psychiatry, 18, 135–40.

T. D.Cannon, , C. E.Bearden, , J. M.Hollister, et al. (2000). Childhood cognitive functioning in schizophrenia patients and their unaffected siblings: a prospective cohort study. Schizophrenia Bulletin, 26, 379–93.

T. D.Cannon, , P. M.Thompson, , T. G.van Erp, et al. (2002). Cortex mapping reveals regionally specific patterns of genetic and disease-specific gray-matter deficits in twins discordant for schizophrenia. Proceedings of the National Academy of Sciences, USA, 99, 3228–33.

T. D.Cannon, , T. G.van Erp, , C. E.Bearden, et al. (2003). Early and late neurodevelopmental influences in the prodrome to schizophrenia: contributions of genes, environment, and their interactions. Schizophrenia Bulletin, 29, 653–69.

T. D.Cannon, , W.Hennah, , T. G.van Erp, et al. (2005). Association of DISC1/TRAX haplotypes with schizophrenia, reduced prefrontal gray matter, and impaired short- and long-term memory. Archives of General Psychiatry, 62, 1205–13.

C. S.Carter, , W.Perlstein, , R.Ganguli, et al. (1998). Functional hypofrontality and working memory dysfunction in schizophrenia. American Journal of Psychiatry, 155, 1285–7.

J.Chi, , E.Dooling, & F.Gilles, (1977). Gyral development of the human brain. Annals of Neurology, 1, 86–93.

B. A.Cornblatt, & J. G.Keilp, (1994). Impaired attention, genetics, and the pathophysiology of schizophrenia. Schizophrenia Bulletin, 20, 31–46.

R.Cosway, , M.Byrne, , R.Clafferty, et al. (2000). Neuropsychological change in young people at high risk for schizophrenia: results from the first two neuropsychological assessments of the Edinburgh High Risk Study. Psychological Medicine, 30, 1111–21.

R.Cosway, , M.Byrne, , R.Clafferty, et al. (2002). Sustained attention in young people at high risk for schizophrenia. Psychological Medicine, 32, 277–86.

A. S.David, , A.Malmberg, , L.Brandt, , P.Allebeck, & G.Lewis, (1997). IQ and risk for schizophrenia: a population-based cohort study. Psychological Medicine, 27, 1311–23.

L. L.Davidson, & R. W.Heinrichs, (2003). Quantification of frontal and temporal lobe brain-imaging findings in schizophrenia: a meta-analysis. Psychiatry Research, 122, 69–87.

C. R.De Luca, , S. J.Wood, , V.Anderson, et al. (2003). Normative data from the CANTAB. I: development of executive function over the lifespan. Journal of Clinical and Experimental Neuropsychology, 25, 242–54.

O. M.de Wilde, , L. J.Bour, , P. M.Dingemans, , J. H.Koelman, & D. H.Linszen, (2007). Failure to find p50 suppression deficits in young first-episode patients with schizophrenia and clinically unaffected siblings. Schizophrenia Bulletin, 33, 1319–23.

D.Dickinson, , M. E.Ramsey, & J. M.Gold, (2007). Overlooking the obvious: a meta-analytic comparison of digit symbol coding tasks and other cognitive measures in schizophrenia. Archives of General Psychiatry, 64, 532–42.

M. F.Egan, , T. E.Goldberg, , B. S.Kolachana, et al. (2001a). Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proceedings of the National Academy of Sciences USA, 98, 6917–22.

L.Erlenmeyer-Kimling, , D.Rock, , S. A.Roberts, et al. (2000). Attention, memory, and motor skills as childhood predictors of schizophrenia-related psychoses: the New York High-risk Project. American Journal of Psychiatry, 157, 1416–22.

U.Ettinger, , M.Picchioni, , M. H.Hall, et al. (2006). Antisaccade performance in monozygotic twins discordant for schizophrenia: the Maudsley twin study. American Journal of Psychiatry, 163, 543–5.

S. F.Faux, , R. W.McCarley, , P. G.Nestor, et al. (1993). P300 topographic asymmetries are present in unmedicated schizophrenics. Electroencephalography and Clinical Neurophysiology, 88, 32–41.

I.Feinberg, (1982). Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence? Journal of Psychiatric Research, 17, 319–34.

J. M.Ford, , P. M.White, , J. G.Csernansky, et al. (1994). ERPs in schizophrenia: effects of antipsychotic medication. Biological Psychiatry, 36, 153–70.

A.Fornito, , M.Yücel, , S. J.Wood, et al. (2006). Morphology of the paracingulate sulcus and executive cognition in schizophrenia. Schizophrenia Research, 88, 192–7.

A.Fornito, , M.Yücel, , S. J.Wood, et al. (2008). Surface-based morphometry of the anterior cingulate cortex in first episode schizophrenia. Human Brain Mapping, 29, 478–89.

S. M.Francey, , H. J.Jackson, , L. J.Phillips, et al. (2005). Sustained attention in young people at high risk of psychosis does not predict transition to psychosis. Schizophrenia Research, 79, 127–36.

S.Frangou, , T.Sharma, , G.Alarcon, et al. (1997). The Maudsley Family Study, II: Endogenous event-related potentials in familial schizophrenia. Schizophrenia Research, 23, 45–53.

R.Freedman, , C. E.Adams, , L. E.Adler, et al. (2000). Inhibitory neurophysiological deficit as a phenotype for genetic investigation of schizophrenia. American Journal of Medical Genetics, 97, 58–64.

D.Friedman, & E.Squires-Wheeler, (1994). Event-related potentials (ERPs) as indicators of risk for schizophrenia. Schizophrenia Bulletin, 20, 63–74.

P.Fusar-Poli, , J.Perez, , M.Broome, et al. (2007a). Neurofunctional correlates of vulnerability to psychosis: a systematic review and meta-analysis. Neurosciences and Biobehavioral Reviews, 31, 465–84.

P.Fusar-Poli, , M. R.Broome, , P.Matthiasson, et al. (2007b). Effects of acute antipsychotic treatment on brain activation in first episode psychosis: an fMRI study. European Neuropsychopharmacology, 17, 492–500.

J. N.Giedd, (2004). Structural magnetic resonance imaging of the adolescent brain. Annals of the New York Academy of Science, 1021, 77–85.

D. C.Glahn, , P. M.Thompson, & J.Blangero, (2007). Neuroimaging endophenotypes: strategies for finding genes influencing brain structure and function. Human Brain Mapping, 28, 488–501.

M. C.Gornick, , A. M.Addington, , A.Sporn, et al. (2005). Dysbindin (DTNBP1, 6p22.3) is associated with childhood-onset psychosis and endophenotypes measured by the Premorbid Adjustment Scale (PAS). Journal of Autism and Developmental Disorders, 35, 831–8.

R. E.Gur, , M. S.Keshavan, & S. M.Lawrie, (2007a). Deconstructing psychosis with human brain imaging. Schizophrenia Bulletin, 33, 921–31.

R. E.Gur, , M. E.Calkins, , R. C.Gur, et al. (2007b). The consortium on the genetics of schizophrenia: neurocognitive endophenotypes. Schizophrenia Bulletin, 33, 49–68.

J.Hall, , H. C.Whalley, , D. E.Job, et al. (2006). A neuregulin 1 variant associated with abnormal cortical function and psychotic symptoms. Nature Neurosciences, 9, 1477–8.

J. M.Harris, , S.Yates, , P.Miller, et al. (2004). Gyrification in first-episode schizophrenia: a morphometric study. Biological Psychiatry, 55, 141–7.

J. M.Harris, , T. W.Moorhead, , P.Miller, et al. (2007). Increased prefrontal gyrification in a large high-risk cohort characterizes those who develop schizophrenia and reflects abnormal prefrontal development. Biological Psychiatry, 62, 722–9.

B. J.Harrison, , M.Yücel, , M.Shaw, et al. (2006). Dysfunction of dorsolateral prefrontal cortex in antipsychotic-naive schizophreniform psychosis. Psychiatry Research, 148, 23–31.

P. J.Harrison, & D. A.Lewis, (2003). Neuropathology of schizophrenia. In S. R.Hirsch & D. R.Weinberger (eds.), Schizophrenia. Oxford: Blackwell Science, pp. 310–25.

S.Heckers, (2001). Neuroimaging studies of the hippocampus in schizophrenia. Hippocampus, 11, 520–8.

R. W.Heinrichs, (2005). The primacy of cognition in schizophrenia. American Psychologist, 60, 229–42.

W.Hennah, , A.Tuulio-Henriksson, , T.Paunio, et al. (2005). A haplotype within the DISC1 gene is associated with visual memory functions in families with a high density of schizophrenia. Molecular Psychiatry, 10, 1097–103.

Y.Hirayasu, , N.Asato, , H.Ohta, et al. (1998). Abnormalities of auditory event-related potentials in schizophrenia prior to treatment. Biological Psychiatry, 43, 244–53.

Y.Hirayasu, , S.Tanaka, , M. E.Shenton, et al. (2001). Prefrontal gray matter volume reduction in first episode schizophrenia. Cerebral Cortex, 11, 374–81.

A. L.Hoff, , C.Svetina, , G.Shields, , J.Stewart, & L. E.DeLisi, (2005). Ten year longitudinal study of neuropsychological functioning subsequent to a first episode of schizophrenia. Schizophrenia Research, 78, 27–34.

H. E.Hulshoff Pol, , H. G.Schnack, , R. C.Mandl, et al. (2006). Gray and white matter density changes in monozygotic and same-sex dizygotic twins discordant for schizophrenia using voxel-based morphometry. Neuroimage, 31, 482–8.

L. J.Ingraham, , S.Kugelmass, , E.Frenkel, , M.Nathan, & A. F.Mirsky, (1995). Twenty-five-year followup of the Israeli High-Risk Study: current and lifetime psychopathology. Schizophrenia Bulletin, 21, 183–92.

D. C.Javitt, , A.Shelley, & W.Ritter, (2000). Associated deficits in mismatch negativity generation and tone matching in schizophrenia. Clinical Neurophysiology, 111, 1733–7.

Y. W.Jeon, & J.Polich, (2001). P300 asymmetry in schizophrenia: a meta-analysis. Psychiatry Research, 104, 61–74.

F.Jessen, , H.Scherk, , F.Träber, et al. (2006). Proton magnetic resonance spectroscopy in subjects at risk for schizophrenia. Schizophrenia Research, 87, 81–8.

Y.Jin, , W. E.Bunney, , Jr, C. A.Sandman, et al. (1998). Is p50 suppression a measure of sensory gating in schizophrenia? Biological Psychiatry, 43, 873–8.

D. E.Job, , H. C.Whalley, , E. C.Johnstone, & S. M.Lawrie, (2005). Grey matter changes over time in high risk subjects developing schizophrenia. Neuroimage, 25, 1023–30.

H. M.Jones, , M. J.Brammer, , M.O’Toole, et al. (2004). Cortical effects of quetiapine in first-episode schizophrenia: a preliminary functional magnetic resonance imaging study. Biological Psychiatry, 56, 938–42.

P.Jones, , B.Rodgers, , R.Murray, & M.Marmot, (1994). Child development risk factors for adult schizophrenia in the British 1946 birth cohort. Lancet, 344, 1398–402.

R. S.Keefe, , R. M.Bilder, , P. D.Harvey, et al. (2006). Baseline neurocognitive deficits in the CATIE schizophrenia trial. Neuropsychopharmacology, 31, 2033–46.

M. S.Keshavan, , K. M.Prasad, & G.Pearlson, (2007). Are brain structural abnormalities useful as endophenotypes in schizophrenia? International Review of Psychiatry, 19, 397–406.

M.Kimble, , M.Lyons, , B.O’Donnell, et al. (2000). The effect of family status and schizotypy on electrophysiologic measures of attention and semantic processing. Biological Psychiatry, 47, 402–12.

J.Klosterkötter, , M.Hellmich, , E. M.Steinmeyer, & F.Schultze-Lutter, (2001). Diagnosing schizophrenia in the initial prodromal phase. Archives of General Psychiatry, 58, 158–64.

W. S.Kremen, , S. L.Buka, , L. J.Seidman, et al. (1998). IQ decline during childhood and adult psychotic symptoms in a community sample: a 19-year longitudinal study. American Journal of Psychiatry, 155, 672–7.

N.Kuroki, , M. E.Shenton, , D. F.Salisbury, et al. (2006). Middle and inferior temporal gyrus gray matter volume abnormalities in first-episode schizophrenia: an MRI study. American Journal of Psychiatry, 163, 2103–10.

A. J.Law, , J. E.Kleinman, , D. R.Weinberger, & C. S.Weickert, (2007). Disease-associated intronic variants in the ErbB4 gene are related to altered ErbB4 splice-variant expression in the brain in schizophrenia. Human Molecular Genetics, 16, 129–41.

S. M.Lawrie, (2004). Premoribid strucutral abnormalities in schizophrenia. In M. S.Keshavan , J. L.Kennedy & R. M.Murray (eds.), Neurodevelopment and Schizophrenia. Cambridge, UK: Cambridge University Press, pp. 347–72.

S. M.Lawrie, & S. S.Abukmeil, (1998). Brain abnormality in schizophrenia: a systematic and quantitative review of volumetric magnetic resonance imaging studies. British Journal of Psychiatry, 172, 110–20.

T.Lencz, , C. W.Smith, , D.McLaughlin, et al. (2006). Generalized and specific neurocognitive deficits in prodromal schizophrenia. Biological Psychiatry, 59, 863–71.

P. F.Liddle, & C.Pantelis, (2003). Brain imaging in schizophrenia. In S. R.Hirsch & D. R.Weinberger (eds.), Schizophrenia. Oxford, UK: Blackwell Science, pp. 403–17.

B.Luna, & J. A.Sweeney, (2001). Studies of brain and cognitive maturation through childhood and adolescence: a strategy for testing neurodevelopmental hypotheses. Schizophrenia Bulletin, 27, 443–55.

B.Luna, & J. A.Sweeney, (2004). The emergence of collaborative brain function: fMRI studies of the development of response inhibition. Annals of the New York Academy of Science, 1021, 296–309.

A. W.MacDonald, , III, C. S.Carter, , J. G.Kerns, et al. (2005). Specificity of prefrontal dysfunction and context processing deficits to schizophrenia in never-medicated patients with first-episode psychosis. American Journal of Psychiatry, 162, 475–84.

D. S.Manoach, , D. Z.Press, , V.Thangaraj, et al. (1999). Schizophrenic subjects activate dorsolateral prefrontal cortex during a working memory task, as measured by fMRI. Biological Psychiatry, 45, 1128–37.

D. S.Manoach, , R. L.Gollub, , E. S.Benson, et al. (2000). Schizophrenic subjects show aberrant fMRI activation of dorsolateral prefrontal cortex and basal ganglia during working memory performance. Biological Psychiatry, 48, 99–109.

D.Marjoram, , D. E.Job, , H. C.Whalley, et al. (2006). A visual joke fMRI investigation into theory of mind and enhanced risk of schizophrenia. Neuroimage, 31, 1850–8.

D. H.Mathalon, , J. M.Ford, & A.Pfefferbaum, (2000). Trait and state aspects of P300 amplitude reduction in schizophrenia: a retrospective longitudinal study. Biological Psychiatry, 47, 434–49.

R. W.McCarley, , M. E.Shenton, , B. F.O’Donnell, et al. (1993). Auditory P300 abnormalities and left posterior superior temporal gyrus volume reduction in schizophrenia. Archives of General Psychiatry, 50, 190–7.

R. W.McCarley, , D. F.Salisbury, , Y.Hirayasu, et al. (2002). Association between smaller left posterior superior temporal gyrus volume on magnetic resonance imaging and smaller left temporal P300 amplitude in first-episode schizophrenia. Archives of General Psychiatry, 59, 321–31.

C.McDonald, , J.Zanelli, , S.Rabe-Hesketh, et al. (2004a). Meta-analysis of magnetic resonance imaging brain morphometry studies in bipolar disorder. Biological Psychiatry, 56, 411–17.

C.McDonald, , E. T.Bullmore, , P. C.Sham, et al. (2004b). Association of genetic risks for schizophrenia and bipolar disorder with specific and generic brain structural endophenotypes. Archives of General Psychiatry, 61, 974–84.

B. L.Miller, , L.Chang, , R.Booth, et al. (1996). In vivo 1H MRS choline: correlation with in vitro chemistry/histology. Life Sciences, 58, 1929–35.

A. F.Mirsky, (1995). Israeli High Risk Study: editor’s introduction. Schizophrenia Bulletin, 21, 179–82.

V.Molina, , J.Sanz, , S.Reig, et al. (2005). Hypofrontality in men with first-episode psychosis. British Journal of Psychiatry, 186, 203–8.

R. A.Morey, , S.Inan, , T. V.Mitchell, et al. (2005). Imaging frontostriatal function in ultra-high-risk, early, and chronic schizophrenia during executive processing. Archives of General Psychiatry, 62, 254–62.

G. K.Murray, , P. B.Jones, , K.Moilanen, et al. (2006). Infant motor development and adult cognitive functions in schizophrenia. Schizophrenia Research, 81, 65–74.

G. K.Murray, , P. B.Jones, , D.Kuh, & M.Richards, (2007). Infant developmental milestones and subsequent cognitive function. Annals of Neurology, 62, 128–36.

R. M.Murray, & S. W.Lewis, (1987). Is schizophrenia a neurodevelopmental disorder? British Medical Journal (Clinical Research Edition), 295, 681–2.

M.Myles-Worsley, , L.Ord, , F.Blailes, , H.Ngiralmau, & R.Freedman, (2004). P50 sensory gating in adolescents from a Pacific island isolate with elevated risk for schizophrenia. Biological Psychiatry, 55, 663–7.

M.Nakamura, , D. F.Salisbury, , Y.Hirayasu, et al. (2007). Neocortical gray matter volume in first-episode schizophrenia and first-episode affective psychosis: a cross-sectional and longitudinal MRI study. Biological Psychiatry, 62, 773–83.

K. L.Narr, , R. M.Bilder, , S.Kim, et al. (2004). Abnormal gyral complexity in first-episode schizophrenia. Biological Psychiatry, 55, 859–67.

M. D.Nelson, , A. J.Saykin, , L. A.Flashman, & H. J.Riordan, (1998). Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging: a meta-analytic study. Archives of General Psychiatry, 55, 433–40.

D.Nieman, , H.Becker, , R.van de Fliert, et al. (2007). Antisaccade task performance in patients at ultra high risk for developing psychosis. Schizophrenia Research, 95, 54–60.

C.Pantelis, & P.Maruff, (2002). The cognitive neuropsychiatric approach to investigating the neurobiology of schizophrenia and other disorders. Journal of Psychosomatic Research, 53, 655–64.

C.Pantelis, , G. W.Stuart, , H. E.Nelson, , T. W.Robbins, & T. R. E.Barnes, (2001). Spatial working memory deficits in schizophrenia: relationship with tardive dyskinesia and negative symptoms. American Journal of Psychiatry, 158, 1276–85.

C.Pantelis, , M.Yücel, , S. J.Wood, et al. (2005). Structural brain imaging evidence for multiple pathological processes at different stages of brain development in schizophrenia. Schizophrenia Bulletin, 31, 672–96.

C.Pantelis, , D.Velakoulis, , S. J.Wood, et al. (2007). Neuroimaging and emerging psychotic disorders: the Melbourne Ultra-High Risk Studies. International Review of Psychiatry, 19, 371–9.

C. M.Pariante, , P.Dazzan, , A.Danese, et al. (2005). Increased pituitary volume in antipsychotic-free and antipsychotic-treated patients of the AEsop first-onset psychosis study. Neuropsychopharmacology, 30, 1923–31.

T.Paus, (2005). Mapping brain maturation and cognitive development during adolescence. Trends in Cognitive Science, 9, 60–8.

L. J.Phillips, , P. D.McGorry, , B.Garner, et al. (2006). Stress, the hippocampus and the hypothalamic–pituitary–adrenal axis: implications for the development of psychotic disorders. Australian and New Zealand Journal of Psychiatry, 40, 725–41.

R.Pukrop, , F.Schultze-Lutter, , S.Ruhrmann, et al. (2006). Neurocognitive functioning in subjects at risk for a first episode of psychosis compared with first- and multiple-episode schizophrenia. Journal of Clinical and Experimental Neuropsychology, 28, 1388–407.

R.Pukrop, , S.Ruhrmann, , F.Schultze-Lutter, et al. (2007). Neurocognitive indicators for a conversion to psychosis: comparison of patients in a potentially initial prodromal state who did or did not convert to a psychosis. Schizophrenia Research, 92, 116–25.

J. L.Rapoport, , A. M.Addington, , S.Frangou, & M. R.Psych, (2005). The neurodevelopmental model of schizophrenia: update 2005. Molecular Psychiatry, 10, 434–49.

A.Reichenberg, , M.Weiser, , M. A.Rapp, et al. (2005). Elaboration on premorbid intellectual performance in schizophrenia: premorbid intellectual decline and risk for schizophrenia. Archives of General Psychiatry, 62, 1297–304.

L.Renoult, , M.Prevost, , M.Brodeur, et al. (2007). P300 asymmetry and positive symptom severity: a study in the early stage of a first episode of psychosis. Schizophrenia Research, 93, 366–73.

J. P.Rhinewine, , T.Lencz, , E. P.Thaden, et al. (2005). Neurocognitive profile in adolescents with early-onset schizophrenia: clinical correlates. Biological Psychiatry, 58, 705–12.

J.Rutschmann, , B.Cornblatt, & L.Erlenmeyer-Kimling, (1977). Sustained attention in children at risk for schizophrenia. Report on a continuous performance test. Archives of General Psychiatry, 34, 571–5.

D. F.Salisbury, , M. E.Shenton, , C. B.Griggs, , A.Bonner-Jackson, & R. W.McCarley, (2002). Mismatch negativity in chronic schizophrenia and first-episode schizophrenia. Archives of General Psychiatry, 59, 686–94.

D. F.Salisbury, , S.Krljes, & R. W.McCarley, (2003). Electrophysiology of schizophrenia. In S. R.Hirsch & D. R.Weinberger (eds.), Schizophrenia. Oxford: Blackwell Science, pp. 298–309.

D. F.Salisbury, , N.Kuroki, , K.Kasai, , M. E.Shenton, & R. W.McCarley, (2007). Progressive and interrelated functional and structural evidence of post-onset brain reduction in schizophrenia. Archives of General Psychiatry, 64, 521–9.

L. J.Seidman, , C.Pantelis, , M. S.Keshavan, et al. (2003). A review and new report of medial temporal lobe dysfunction as a vulnerability indicator for schizophrenia: a magnetic resonance imaging morphometric family study of the parahippocampal gyrus. Schizophrenia Bulletin, 29, 803–30.

N.Smyrnis, , I.Evdokimidis, , N. C.Stefanis, et al. (2003). Antisaccade performance of 1273 men: effects of schizotypy, anxiety, and depression. Journal of Abnormal Psychology, 112, 403–14.

B. E.Snitz, , A.MacDonald, , III, J. D.Cohen, et al. (2005). Lateral and medial hypofrontality in first-episode schizophrenia: functional activity in a medication-naive state and effects of short-term atypical antipsychotic treatment. American Journal of Psychiatry, 162, 2322–9.

B. E.Snitz, , A. W.Macdonald, III, & C. S.Carter, (2006). Cognitive deficits in unaffected first-degree relatives of schizophrenia patients: a meta-analytic review of putative endophenotypes. Schizophrenia Bulletin, 32, 179–94.

S. R.Sponheim, , K. A.McGuire, & J. J.Stanwyck, (2006). Neural anomalies during sustained attention in first-degree biological relatives of schizophrenia patients. Biological Psychiatry, 60, 242–52.

A. C.Stanfield, , T. W.Moorhead, , J. M.Harris, et al. (2007). Increased right prefrontal cortical folding in adolescents at risk of schizophrenia for cognitive reasons. Biological Psychiatry, 63, 80–5.

R. G.Steen, , C.Mull, , R.McClure, , R. M.Hamer, & J. A.Lieberman, (2006). Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies. British Journal of Psychiatry, 188, 510–18.

H.Stefansson, , E.Sigurdsson, , V.Steinthorsdottir, et al. (2002). Neuregulin 1 and susceptibility to schizophrenia. American Journal of Human Genetics, 71, 877–92.

W. S.Stone, , S. V.Faraone, , L. J.Seidman, , E. A.Olson, & M. T.Tsuang, (2005). Searching for the liability to schizophrenia: concepts and methods underlying genetic high-risk studies of adolescents. Journal of Child and Adolescent Psychopharmacology, 15, 403–17.

R. E.Straub, , B. K.Lipska, , M. F.Egan, et al. (2007). Allelic variation in GAD1 (GAD(67)) is associated with schizophrenia and influences cortical function and gene expression. Molecular Psychiatry, 12, 854–69.

N. R.Swerdlow, , G. A.Light, , K. S.Cadenhead, et al. (2006). Startle gating deficits in a large cohort of patients with schizophrenia: relationship to medications, symptoms, neurocognition, and level of function. Archives of General Psychiatry, 63, 1325–35.

A.Taanila, , G. K.Murray, , J.Jokelainen, , M.Isohanni, & P.Rantakallio, (2005). Infant developmental milestones: a 31-year follow-up. Developmental Medicine and Child Neurology, 47, 581–6.

P. M.Thompson, , R. P.Woods, , M. S.Mega, & A. W.Toga, (2000). Mathematical/computational challenges in creating deformable and probabilistic atlases of the human brain. Human Brain Mapping, 9, 81–92.

B. I.Turetsky, , T. D.Cannon, & R. E.Gur, (2000). P300 subcomponent abnormalities in schizophrenia: III. Deficits in unaffected siblings of schizophrenic probands. Biological Psychiatry, 47, 380–90.

B. I.Turetsky, , M. E.Calkins, , G. A.Light, et al. (2007). Neurophysiological endophenotypes of schizophrenia: the viability of selected candidate measures. Schizophrenia Bulletin, 33, 69–94.

T. G.van Erp, , P. A.Saleh, , M.Huttunen, et al. (2004). Hippocampal volumes in schizophrenic twins. Archives of General Psychiatry, 61, 346–53.

N. E.van Haren, , M. M.Picchioni, , C.McDonald, et al. (2004). A controlled study of brain structure in monozygotic twins concordant and discordant for schizophrenia. Biological Psychiatry, 56, 454–61.

J. D.Van Horn, & I. C.McManus, (1992). Ventricular enlargement in schizophrenia. A meta-analysis of studies of the ventricle:brain ratio (VBR). British Journal of Psychiatry, 160, 687–97.

D.Velakoulis, & C.Pantelis, (1996). What have we learned from functional imaging studies in schizophrenia? The role of frontal, striatal and temporal areas. Australian and New Zealand Journal of Psychiatry, 30, 195–209.

D.Velakoulis, , S. J.Wood, , M. T.Wong, et al. (2006). Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals. Archives of General Psychiatry, 63, 139–49.

C. N.Vidal, , J. L.Rapoport, , K. M.Hayashi, et al. (2006). Dynamically spreading frontal and cingulate deficits mapped in adolescents with schizophrenia. Archives of General Psychiatry, 63, 25–34.

A.Vita, , L.de Peri, , C.Silenzi, & M.Dieci, (2006). Brain morphology in first-episode schizophrenia: a meta-analysis of quantitative magnetic resonance imaging studies. Schizophrenia Research, 82, 75–88.

K.Vogeley, , T.Schneider-Axmann, , U.Pfeiffer, et al. (2000). Disturbed gyrification of the prefrontal region in male schizophrenic patients: a morphometric postmortem study. American Journal of Psychiatry, 157, 34–9.

K.Vogeley, , R.Tepest, , U.Pfeiffer, et al. (2001). Right frontal hypergyria differentiation in affected and unaffected siblings from families multiply affected with schizophrenia: a morphometric MRI study. American Journal of Psychiatry, 158, 494–6.

E.Walker, & A. M.Bollini, (2002). Pubertal neurodevelopment and the emergence of psychotic symptoms. Schizophrenia Research, 54, 17–23.

M.Walterfang, , A.Wood, , D. C.Reutens, et al. (2008). Morphology of the corpus callosum at different stages of schizophrenia: a cross-sectional study in first-episode and chronic illness. British Journal of Psychiatry, 192, 429–34.

J.Wang, , Y.Hirayasu, , H.Hokama, et al. (2005). Influence of duration of untreated psychosis on auditory P300 in drug-naive and first-episode schizophrenia. Psychiatry and Clinical Neuroscience, 59, 209–14.

S.Weintraub, (1987). Risk factors in schizophrenia: the Stony Brook High-Risk Project. Schizophrenia Bulletin, 13, 439–50.

H. C.Whalley, , E.Simonotto, , W.Moorhead, et al. (2006). Functional imaging as a predictor of schizophrenia. Biological Psychiatry, 60, 454–62.

H. C.Whalley, , J. C.Harris, & S. M.Lawrie, (2007). The neurobiological underpinnings of risk and conversion in relatives of patients with schizophrenia. International Review of Psychiatry, 19, 383–97.

M. C.Whyte, , C.Brett, , L. K.Harrison, et al. (2006). Neuropsychological performance over time in people at high risk of developing schizophrenia and controls. Biological Psychiatry, 59, 730–9.

L. C.Wiegand, , S. K.Warfield, , J. J.Levitt, et al. (2005). An in vivo MRI study of prefrontal cortical complexity in first-episode psychosis. American Journal of Psychiatry, 162, 65–70.

J. J.Wisco, , G.Kuperberg, , D.Manoach, et al. (2007). Abnormal cortical folding patterns within Broca’s area in schizophrenia: evidence from structural MRI. Schizophrenia Research, 94, 317–27.

L. E.Wolf, , B. A.Cornblatt, , S. A.Roberts, , B. M.Shapiro, & L.Erlenmeyer-Kimling, (2002). Wisconsin card sorting deficits in the offspring of schizophrenics in the New York High-Risk Project. Schizophrenia Research, 57, 173–82.

S. J.Wood, , C.Pantelis, , T.Proffitt, et al. (2003). Spatial working memory ability is a marker of risk-for-psychosis. Psychological Medicine, 33, 1239–47.

S. J.Wood, , G.Berger, , D.Velakoulis, et al. (2003b). Proton magnetic resonance spectroscopy in first episode psychosis and ultra high-risk individuals. Schizophrenia Bulletin, 29, 831–43.

S. J.Wood, , C. R.De Luca, , V.Anderson, & C.Pantelis, (2004). Cognitive development in adolescence: cerebral underpinnings, neural trajectories and the impact of aberrations. In M. S.Keshavan , J. L.Kennedy & R. M.Murray , (eds.), Neurodevelopment and Schizophrenia. Cambridge, UK: Cambridge University Press, pp. 69–88.

S. J.Wood, , M.Yücel, , D.Velakoulis, et al. (2005). Hippocampal and anterior cingulate morphology in subjects at ultra-high-risk for psychosis: the role of family history of psychotic illness. Schizophrenia Research, 75, 295–301.

S. J.Wood, , W. J.Brewer, , P.Koutsouradis, et al. (2007). Cognitive decline following psychosis onset: Data from the PACE clinic. British Journal of Psychiatry, 191(Suppl 51), s52–7.

S. J.Wood, , C.Pantelis, , D.Velakoulis, et al. (2008). Progressive changes in the development towards schizophrenia: studies in subjects at increased symptomatic risk. Schizophrenia Bulletin, 34, 322–9.

B. T.Woods, , K. E.Ward, & E. H.Johnson, (2005). Meta-analysis of the time-course of brain volume reduction in schizophrenia: implications for pathogenesis and early treatment. Schizophrenia Research, 73, 221–8.

I. C.Wright, , S.Rabe-Hesketh, , P. W.Woodruff, et al. (2000). Meta-analysis of regional brain volumes in schizophrenia. American Journal of Psychiatry, 157, 16–25.

M.Yücel, , G. W.Stuart, , P.Maruff, et al. (2001). Hemispheric and gender-related differences in the gross morphology of the anterior cingulate/paracingulate cortex in normal volunteers: an MRI morphometric study. Cerebral Cortex, 11, 17–25.

M.Yücel, , G. W.Stuart, , P.Maruff, et al. (2002). Paracingulate morphological differences in males with established schizophrenia: a magnetic resonance imaging morphometric study. Biological Psychiatry, 52, 15–23.

M.Yücel, , S. J.Wood, , L. J.Phillips, et al. (2003). Morphology of the anterior cingulate cortex in young men at ultra-high risk of developing a psychotic illness. British Journal of Psychiatry, 182, 518–24.

C.Altamura, , G.Guercetti, & M.Percudani, (1989). Dexamethasone suppression test in positive and negative schizophrenia. Psychiatry Research, 30, 69–75.

G. M.Asnis, , U.Halbreich, , N. D.Ryan, et al. (1987). The relationship of the dexamethasone suppression test (1-mg and 2-mg) to basal plasma cortisol levels in endogenous depression. Psychoneuroendocrinology, 12, 295–301.

M.Bak, , I.Myin-Germeys, , M.Hanssen, et al. (2003). When does experience of psychosis result in a need for care? A prospective general population study. Schizophrenia Bulletin, 29, 349–58.

A.Bechdolf, , S.Ruhrmann, , M.Wagner, et al. (2005a). Interventions in the initial prodromal states of psychosis in Germany: concept and recruitment. British Journal of Psychiatry, 187, s45–8. [Special Issue: Early Psychosis: A Bridge to the Future.]

A.Bechdolf, , D.Kohn, , B.Knost, , R.Pukrop, & J.Klosterkötter, (2005b). A randomized comparison of group cognitive–behavioural therapy and group psychoeducation in acute patients with schizophrenia: outcome at 24 months. Acta Psychiatrica Scandinavica, 112, 173–9.

A.Bechdolf, , V.Veith, , D.Schwarzer, et al. (2005c). Cognitive– behavioral therapy in the pre-psychotic phase: an exploratory study. Psychiatry Research, 136, 251–5.

A.Bechdolf, , L. J.Phillips, , S.Francey, et al. (2006). Recent approaches to psychological interventions for people at risk of psychosis. European Archives of Psychiatry and Neuroscience, 256, 159–73.

R. P.Bentall, & A. P.Morrison, (2002). More harm than good: the case against using antipsychotic drugs to prevent severe mental illness. Journal of Mental Health, 11, 351–6.

B.Bogerts, , M.Ashtari, , G.Degreef, et al. (1990). Reduced temporal limbic structure volumes on magnetic resonance images in first episode schizophrenia. Psychiatry Research, 35, 1–13.

B.Bogerts, , J. A.Lieberman, , M.Ashtari, et al. (1993). Hippocampus–amygdala volumes and psychopathology in chronic schizophrenia. Biological Psychiatry, 33, 236–46.

W. J.Brewer, , C.Pantelis, , V.Anderson, et al. (2001). Stability of